Skip to content
Contact
Back to network
12Division

Segal Health

Longevity and biofabrication.

Overview

We don't treat. We rebuild.

Segal Health applies the Segal engineering discipline to the hardest frontier of all — the human body. We print replacement organs, regrow tissue from a patient's own cells, and manufacture the molecules that sharpen the mind. Designed, fabricated, and delivered, under one roof.

Three divisions share a single biofabrication core: Regenerative bioprints replacement organs and body parts, Longevity runs stem-cell research for life extension, and Neuropharm manufactures GMP-grade neuropharmaceuticals. One algorithm — resolve, design, fabricate, validate, deliver — applied to different biological feedstock.

3
Divisions, one biofabrication core
6
Programs across the pipeline
9
Shared platform capabilities
0
Donors required — printed from patient cells
2,025
Founded
Capabilities
REGENERATIVE

Segal Regenerative

Autonomous 3D bioprinting of replacement organs and body parts. We image a patient, model the structure, and print living tissue from their own cells — ending the donor waitlist and the rejection that follows it.

LONGEVITY

Segal Longevity

Stem-cell research for human life extension. We reprogram and deploy a patient's own cells to repair tissue, reset biological age markers, and treat the diseases of aging at their cellular root rather than their symptoms.

NEUROPHARM

Segal Neuropharm

Precision pharmaceutical manufacturing for the mind. GMP-grade stimulants and psychedelic compounds — for focus, and for the treatment of depression, PTSD, and addiction — made to a purity and consistency the clinic can trust.

REGENERATIVE

Perfusable vascular lattice

Prints sacrificial channels that are later dissolved and endothelialized into a perfusable network — the prerequisite for keeping solid organs alive beyond the ~200µm oxygen diffusion limit.

LONGEVITY

Partial-reprogramming protocol

Applies reprogramming factors transiently and cyclically to roll back epigenetic age while preserving cell identity. Full reprogramming is deliberately avoided — it risks loss of function and teratoma.

NEUROPHARM

GMP synthesis line

Produces CNS-active compounds under ICH-aligned GMP with documented in-process controls and batch release. Vertical integration keeps identity, potency, and purity under one roof.

Case Studies
REGENERATIVE — TRIAL

Bioprinted Cartilage Graft

Patient-matched cartilage for joint and airway repair, printed from autologous chondrocytes. Cartilage is avascular, so the graft needs no built-in blood supply — the honest place to start. First-in-human trials underway.

REGENERATIVE — RESEARCH

Printed Renal Construct

A vascularized kidney construct printed around a sacrificial channel network, feeding tissue past the ~200µm diffusion limit — the path off dialysis and the transplant list. Pre-clinical.

LONGEVITY — RESEARCH

Age-Reversal Cell Therapy

Partial reprogramming of patient-derived cells to reset epigenetic age markers without erasing identity, then returned to repair tissue. Beginning with the eye and immune system. Pre-clinical.

NEUROPHARM — CLINICAL

Cognition Stimulant — GMP

Single-enantiomer stimulant therapeutics for ADHD and focus, synthesized on GMP lines and released only after identity, potency, and chiral-purity testing. Supplied to licensed clinical partners.

NEUROPHARM — TRIAL

Psilocybin Therapeutic

Standardized, analytically-pure psilocybin for treatment-resistant depression and PTSD. Consistency is the therapeutic variable, so purity is the deliverable. Supplied to authorized trial sites under chain-of-custody.